Anxiolytics
Anxiety is a common symptom of various psychiatric disorders, while anxiety disorder is a kind of neurosis characterized by repetitive acute anxiety and accompanied by autonomic dysfunction. When it attacks, the patients mainly show consciously fear, tension, anxiety, palpitations, cold sweats, tremor and sleep disorders. Whether anxiety or anxiety disorder all use anxiolytic drugs for clinic treatment. Many psychosomatic diseases, mental and organic diseases, menopausal syndrome and stress state are also accompanied by anxiety. Anxiolytic drugs are those drugs that selectively eliminate anxiety without significantly affecting other functions of the central nervous system. Commonly-used anxiolytic drugs include the benzodiazepine drugs represented by diazepam and the propylene glycol characterized by methallyl carbamate. Sedative hypnotics, antipsychotics, antidepressants, β-blockers, and the like, also have anti-depressants effects, and the drugs that prevent 5-HT reabsorption have a good anxiolytic effect too.
Click on the specific product, view the latest prices of the products, information, serving information
| Structure |
Chemical Name |
CAS |
MF |
 |
alpha,alpha-Diphenyl-4-piperidinomethanol |
115-46-8 |
C18H21NO |
 |
Vortioxetine |
508233-74-7 |
C18H22N2S |
 |
Vortioxetine hydrobromide |
960203-27-4 |
C18H23BrN2S |
 |
NA-Selank |
|
|
 |
Adatanserin hydrochloride |
144966-96-1 |
C21H31N5O. HCl |
 |
Etifoxine |
21715-46-8 |
C17H17ClN2O |
 |
Flutazolam |
27060-91-9 |
C19H18ClFN2O3 |
 |
Triflubazam |
22365-40-8 |
C17H13F3N2O2 |
 |
ipsapirone |
92589-98-5 |
C19H24ClN5O3S |
 |
2-METHYL-2-(1-METHYLPROPYL)-1,3-PROPANEDIOL DICARBAMATE |
64-55-1 |
C10H20N2O4 |
 |
Orvepitant maleate |
579475-24-4 |
C35H39F7N4O6 |
 |
Talaglumetad hydrochloride |
441765-97-5 |
C11H17ClN2O5 |
 |
Zalospirone hydrochloride |
114374-97-9 |
C24H30ClN5O2 |
 |
PIRENPERONE |
75444-65-4 |
C23H24FN3O2 |
 |
7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-benzo-1,4-diazepine monohydrochloride |
2898-11-5 |
C16H16Cl2N2 |
![Acetamide, N-[3-[4-[4-[[(cyclohexylmethyl)sulfonyl]amino]butyl]-1-piperazinyl]phenyl]-, hydrochloride (1:1)](/CAS/20211123/GIF/740873-82-9.gif) |
Acetamide, N-[3-[4-[4-[[(cyclohexylmethyl)sulfonyl]amino]butyl]-1-piperazinyl]phenyl]-, hydrochloride (1:1) |
740873-82-9 |
C23H39ClN4O3S |
 |
Panadiplon |
124423-84-3 |
C18H17N5O2 |
 |
Sulazepam |
2898-13-7 |
C16H13ClN2S |
 |
Clazolam |
7492-29-7 |
C18H17ClN2O |
 |
Pancopride |
121650-80-4 |
C18H24ClN3O2 |
 |
DAU 6215 |
123258-84-4 |
C16H20N4O2 |
 |
Flesinoxan |
98206-10-1 |
C22H26FN3O4 |
 |
captodiame |
486-17-9 |
C21H29NS2 |
 |
Pentabamate |
5667-70-9 |
C8H16N2O4 |
 |
Octanoic acid, 3-aMino-5-Methyl-, hydrochloride (1:1), (3S,5R)- |
610300-00-0 |
C9H20ClNO2 |
 |
abecarnil |
111841-85-1 |
C24H24N2O4 |
 |
Flutoprazepam |
25967-29-7 |
C19H16ClFN2O |
 |
Pexacerfont |
459856-18-9 |
C18H24N6O |
 |
tybamate |
4268-36-4 |
C13H26N2O4 |
 |
Pivagabine |
69542-93-4 |
C9H17NO3 |
 |
Sunepitron |
148408-65-5 |
C17H23N5O2 |
 |
(3S,5R)-3-Amino-5-methyloctanoic acid |
610300-07-7 |
C9H19NO2 |
 |
TOFISOPAM |
22345-47-7 |
C22H26N2O4 |
![PYRIDIN-2-YL-[7-PYRIDIN-4-YL-PYRAZOLE[1,5-A]PYRIMIDIN-3-YL]METHANONE](/CAS/GIF/96604-21-6.gif) |
PYRIDIN-2-YL-[7-PYRIDIN-4-YL-PYRAZOLE[1,5-A]PYRIMIDIN-3-YL]METHANONE |
96604-21-6 |
C17H11N5O |
 |
6-chloro-N-ethyl-4-methyl-4-phenyl-4H-3,1-benzoxazin-2-amine monohydrochloride |
56776-32-0 |
C17H18Cl2N2O |
 |
proxibarbal |
2537-29-3 |
C10H14N2O4 |
 |
DEXTOFISOPAM,(R)-(5R)-1-(3,4-DIMETHOXYPHENYL)-5-ETHYL-7,8-DIMETHOXY-4-METHYL-5H-2,3-BENZODIAZEPINE |
82059-50-5 |
C22H26N2O4 |
 |
orvepitant |
579475-18-6 |
C31H35F7N4O2 |
 |
4,16-ANDROSTADIEN-3-BETA-OL |
23062-06-8 |
C19H28O |
 |
Taclamine hydrochloride |
34061-34-2 |
C21H24ClN |
 |
Oxaflozane |
26629-87-8 |
C14H18F3NO |
![(±)-4-(2-methoxyphenyl)-alpha-[(3,4,5-trimethoxyphenoxy)methyl]piperazine-1-ethanol dihydrochloride](/CAS/20180713/GIF/68576-88-5.gif) |
(±)-4-(2-methoxyphenyl)-alpha-[(3,4,5-trimethoxyphenoxy)methyl]piperazine-1-ethanol dihydrochloride |
68576-88-5 |
C23H34Cl2N2O6 |
 |
(S)-Tofisopam |
82059-51-6 |
C22H26N2O4 |
 |
Casopitant mesylate |
414910-30-8 |
C30H35F7N4O2.CH4O3S |
 |
Gedocarnil |
109623-97-4 |
C23H21ClN2O4 |
 |
Nisobamate |
25269-04-9 |
C13H26N2O4 |
![Lorzafone [USAN:INN]](/CAS/20180808/GIF/81603-65-8.gif) |
Lorzafone [USAN:INN] |
81603-65-8 |
C18H19Cl2N3O4 |
 |
ALPHA-PHENYL-1-(2-PHENYLETHYL)-4-PIPERIDINEMETHANOL |
107703-78-6 |
C20H25NO |
 |
ETHYL LOFLAZEPATE |
29177-84-2 |
C18H14ClFN2O3 |
 |
VESTIPITANT MESYLATE |
334476-64-1 |
C24H28F7N3O4S |
![N-[3-[4-[4-[(Cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide](/CAS2/GIF/740873-06-7.gif) |
N-[3-[4-[4-[(Cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide |
740873-06-7 |
C23H38N4O3S |
 |
mirisetron maleate |
148611-75-0 |
C24H31N3O2.C4H4O4 |
![2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID HYDRATE](/CAS/GIF/209216-09-1.gif) |
2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID HYDRATE |
209216-09-1 |
|
![8-[2-(1,4-BENZODIOXAN-2-YLMETHYLAMINO)ETHYL]-8-AZASPIRO[4.5]DECANE-7,9-DIONE HYDROCHLORIDE](/CAS/GIF/124756-23-6.gif) |
8-[2-(1,4-BENZODIOXAN-2-YLMETHYLAMINO)ETHYL]-8-AZASPIRO[4.5]DECANE-7,9-DIONE HYDROCHLORIDE |
124756-23-6 |
C20H27ClN2O4 |
 |
Carisoprodol |
78-44-4 |
C12H24N2O4 |
 |
mexazolam |
31868-18-5 |
C18H16Cl2N2O2 |
 |
Buspirone |
36505-84-7 |
C21H31N5O2 |
 |
emylcamate |
78-28-4 |
C7H15NO2 |
 |
Hydroxyzine |
68-88-2 |
C21H27ClN2O2 |
 |
Hydroxyzine dihydrochloride |
2192-20-3 |
C21H29Cl3N2O2 |
 |
Ergoline-8-beta-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, tar trate (1:1), d- |
32426-57-6 |
C20H25N3O.C4H6O6 |
 |
CGS 15040A |
117581-05-2 |
C22H24ClN3O2 |
 |
Alpidem |
82626-01-5 |
C21H23Cl2N3O |
 |
Enciprazine |
68576-86-3 |
C23H32N2O6 |
|
|
Etizolam JP |
|
|
 |
Chlormezanone |
80-77-3 |
C11H12ClNO3S |
 |
Buspirone hydrochloride |
33386-08-2 |
C21H32ClN5O2 |
 |
ectylurea |
95-04-5 |
C7H12N2O2 |